prednisolone acetate has been researched along with Sarcoidosis, Pulmonary in 1 studies
prednisolone acetate: RN given refers to cpd with locant for acetate group in position 21 & (11 beta)-isomer
Sarcoidosis, Pulmonary: Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (Cecil Textbook of Medicine, 19th ed, p431)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caprioli, J | 1 |
| Samson, CM | 1 |
| Foster, CS | 1 |
| Araie, M | 1 |
| Rockwood, EJ | 1 |
1 other study available for prednisolone acetate and Sarcoidosis, Pulmonary
| Article | Year |
|---|---|
Uveitis and glaucoma.
Topics: Antihypertensive Agents; Cataract; Cataract Extraction; Cyclopentolate; Drug Therapy, Combination; F | 2000 |